APA (7th ed.) Citation

Lin, P., Yeh, Y., Chan, R., Lin, B., Chen, P., Pan, C., & Shen, M. (2021). Sequential and co-occurring DNA damage response genetic mutations impact survival in stage III colorectal cancer patients receiving adjuvant oxaliplatin-based chemotherapy. BMC cancer, 21(1), 217-11. https://doi.org/10.1186/s12885-021-07926-1

Chicago Style (17th ed.) Citation

Lin, Peng-Chan, Yu-Min Yeh, Ren-Hao Chan, Bo-Wen Lin, Po-Chuan Chen, Chien-Chang Pan, and Meng-Ru Shen. "Sequential and Co-occurring DNA Damage Response Genetic Mutations Impact Survival in Stage III Colorectal Cancer Patients Receiving Adjuvant Oxaliplatin-based Chemotherapy." BMC Cancer 21, no. 1 (2021): 217-11. https://doi.org/10.1186/s12885-021-07926-1.

MLA (9th ed.) Citation

Lin, Peng-Chan, et al. "Sequential and Co-occurring DNA Damage Response Genetic Mutations Impact Survival in Stage III Colorectal Cancer Patients Receiving Adjuvant Oxaliplatin-based Chemotherapy." BMC Cancer, vol. 21, no. 1, 2021, pp. 217-11, https://doi.org/10.1186/s12885-021-07926-1.